SEVEN EIGHT CAPITAL, LP - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 172 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEVEN EIGHT CAPITAL, LP ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$527,0000.0%33,8000.0%0.12%
+0.8%
Q4 2020$527,000
+113.4%
33,800
+29.2%
0.12%
+126.4%
Q3 2020$247,000
-44.9%
26,155
-44.4%
0.05%
+120.8%
Q1 2019$448,000
-62.7%
47,000
-25.7%
0.02%
-75.8%
Q1 2018$1,202,000
+230.2%
63,289
+185.1%
0.10%
+167.6%
Q4 2017$364,00022,2000.04%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Rokos Capital Management LLP 6,474,348$11,394,8520.84%
WASATCH ADVISORS LP 13,642,417$24,010,6540.15%
Avidity Partners Management LP 2,470,000$4,347,2000.14%
Acrisure Capital Management, LLC 75,832$133,4640.14%
Golden State Equity Partners 135,765$238,9460.13%
Long Focus Capital Management, LLC 1,072,000$1,886,7200.11%
KLK CAPITAL MANAGEMENT LLC 44,323$78,0080.10%
CAXTON ASSOCIATES LP 288,218$507,2640.08%
XTX Topco Ltd 206,334$363,1480.08%
Rhenman & Partners Asset Management AB 314,157$534,0670.06%
View complete list of SANGAMO THERAPEUTICS INC shareholders